MetLife Investment Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.17M | Sell |
19,381
-502
| -3% | -$136K | 0.03% | 605 |
|
|
2025
Q4 | $4.99M | Sell |
19,883
-745
| -4% | -$198K | 0.02% | 627 |
|
|
2025
Q3 | $5.92M | Sell |
20,628
-696
| -3% | -$186K | 0.03% | 561 |
|
|
2025
Q2 | $5.6M | Sell |
21,324
-346
| -2% | -$84.3K | 0.03% | 530 |
|
|
2025
Q1 | $5.04M | Sell |
21,670
-475
| -2% | -$115K | 0.03% | 610 |
|
|
2024
Q4 | $5.08M | Buy |
22,145
+311
| +1% | +$71.3K | 0.03% | 554 |
|
|
2024
Q3 | $4.88M | Sell |
21,834
-644
| -3% | -$142K | 0.03% | 539 |
|
|
2024
Q2 | $4.57M | Buy |
22,478
+2,602
| +13% | +$529K | 0.03% | 536 |
|
|
2024
Q1 | $4.34M | Sell |
19,876
-730
| -4% | -$161K | 0.03% | 570 |
|
|
2023
Q4 | $4.68M | Sell |
20,606
-1,304
| -6% | -$274K | 0.03% | 490 |
|
|
2023
Q3 | $4.41M | Sell |
21,910
-4,264
| -16% | -$899K | 0.03% | 474 |
|
|
2023
Q2 | $5.43M | Sell |
26,174
-439
| -2% | -$85.2K | 0.04% | 399 |
|
|
2023
Q1 | $5.25M | Sell |
26,613
-320
| -1% | -$65.8K | 0.04% | 415 |
|
|
2022
Q4 | $5.45M | Sell |
26,933
-996
| -4% | -$195K | 0.04% | 387 |
|
|
2022
Q3 | $4.91M | Sell |
27,929
-1,138
| -4% | -$233K | 0.04% | 416 |
|
|
2022
Q2 | $5.85M | Sell |
29,067
-421
| -1% | -$89.7K | 0.05% | 350 |
|
|
2022
Q1 | $6.68M | Buy |
29,488
+4,875
| +20% | +$1.15M | 0.04% | 367 |
|
|
2021
Q4 | $6.64M | Sell |
24,613
-811
| -3% | -$201K | 0.05% | 301 |
|
|
2021
Q3 | $6.15M | Sell |
25,424
-927
| -4% | -$234K | 0.06% | 297 |
|
|
2021
Q2 | $6.24M | Sell |
26,351
-721
| -3% | -$164K | 0.05% | 297 |
|
|
2021
Q1 | $5.93M | Sell |
27,072
-461
| -2% | -$92.5K | 0.05% | 319 |
|
|
2020
Q4 | $4.81M | Sell |
27,533
-1,212
| -4% | -$209K | 0.05% | 369 |
|
|
2020
Q3 | $4.65M | Sell |
28,745
-845
| -3% | -$134K | 0.05% | 338 |
|
|
2020
Q2 | $4.22M | Buy |
29,590
+456
| +2% | +$63.1K | 0.05% | 364 |
|
|
2020
Q1 | $3.16M | Sell |
29,134
-891
| -3% | -$128K | 0.04% | 416 |
|
|
2019
Q4 | $4.36M | Sell |
30,025
-923
| -3% | -$133K | 0.05% | 421 |
|
|
2019
Q3 | $4.47M | Sell |
30,948
-656
| -2% | -$95.7K | 0.05% | 377 |
|
|
2019
Q2 | $4.69M | Sell |
31,604
-1,024
| -3% | -$143K | 0.05% | 377 |
|
|
2019
Q1 | $4.29M | Sell |
32,628
-959
| -3% | -$118K | 0.05% | 407 |
|
|
2018
Q4 | $3.65M | Sell |
33,587
-919
| -3% | -$123K | 0.04% | 417 |
|
|
2018
Q3 | $5.15M | Sell |
34,506
-548
| -2% | -$83.4K | 0.05% | 353 |
|
|
2018
Q2 | $5.41M | Sell |
35,054
-641
| -2% | -$96.8K | 0.06% | 279 |
|
|
2018
Q1 | $4.96M | Sell |
35,695
-969
| -3% | -$142K | 0.06% | 322 |
|
|
2017
Q4 | $5.02M | Buy |
+36,664
| New | +$4.85M | 0.06% | 325 |
|
Other funds holding LH
VCM
VPM
MetLife Investment Management's LH Position: Q1 2026 in Review
MetLife Investment Management reduced its Labcorp (LH) stake by 2.5% in Q1 2026, selling an estimated $136K and leaving 19,381 shares worth $5.17M. The position accounts for 0.03% of the portfolio, ranked #605.
MetLife Investment Management first reported a position in LH in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.68M in Q1 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- MetLife Investment Management held 19,381 shares of Labcorp worth $5.17M as of Q1 2026.
- MetLife Investment Management sold 502 Labcorp shares in Q1 2026, an estimated $136K.
- Labcorp made up 0.03% of MetLife Investment Management's portfolio in Q1 2026, its #605 holding.
- MetLife Investment Management first reported a position in Labcorp in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Labcorp position peaked at $6.68M in Q1 2022.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.